Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Meperidine (compound)


PubChem
Name: Meperidine
PubChem Compound ID: 4058
Description: A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.
Molecular formula: C15H21NO2
Molecular weight: 247.333 g/mol
Synonyms:
S 140; Antidurol; Demerol; 1-Methyl-4-phenylisonipecotic acid ethyl ester hydrochloride; Chlorbycyclen; Dolenal; Dolosal; Meperidine hydrochloride; Centralgin; 1-Methyl-4-phenylisonipecotic acid, ethyl ester.
show more »
DrugBank
Identification
Name: Meperidine
Name (isomeric): DB00454
Drug Type: small molecule
Description: A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.
Brand: Dolantin, Piridosal, Nemerol, Demerol, Piperosal, Pethidine, Petydyna, Dispadol, Pethidin, Methyl phenylpiperidine carbonic acid ethyl ester, Lydol, Pipersal, Pethanol, Meperidine Hcl, Phetidine, Dolcontral, Centralgin, Operidine, Petantin, Lidol, Isonipecaine, Demarol, Pethidineter, Meperidol, Dolsin, Dolosal
Category: Adjuvants, Anesthesia, Narcotics, Adjuvants, Analgesics, Opiate Agonists, Analgesics, Opioid
CAS number: 57-42-1
Pharmacology
Indication: Used to control moderate to severe pain.
Pharmacology:
Meperidine is a synthetic opiate agonist belonging to the phenylpiperidine class. Meperidine may produce less smooth muscle spasm, constipation, and depression of the cough reflex than equivalent doses of morphine. The onset of action is lightly more rapid than with morphine, and the duration of action is slightly shorter. The chemical structure of...
show more »
Mechanism of Action:
Meperidine is primarily a kappa-opiate receptor agonist and also has local anesthetic effects. Meperidine has more affinity for the kappa-receptor than morphine. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding...
show more »
Absorption: The oral bioavailability of meperidine in patients with normal hepatic function is 50-60% due to extensive first-pass metabolism. Bioavailability increases to 80-90% in patients with hepatic impairment (e.g. liver cirrhosis). Meperidine is less than half as effective when administered orally compared to parenteral administration. One study reported that 80-85% of the drug administered intramuscularly was absorbed within 6 hours of intragluteal injection in health adults; however, inter-individual variation and patient-specific variable appear to cause considerable variations in absorption upon IM injection.
Protein binding: 60-80% bound to plasma proteins, primarily albumin and α1-acid glycoprotein. The presence of cirrhosis or active viral hepatitis does not appear to affect the extent of protein binding.
Biotransformation: Meperidine is metabolized in the liver by hydrolysis to meperidinic acid followed by partial conjugation with glucuronic acid. Meperidine also undergoes N-demethylation to normeperidine, which then undergoes hydrolysis and partial conjugation. Normeperidine is about half as potent as meperidine, but it has twice the CNS stimulation effects.
Route of elimination: Excreted in the urine. The proportion of drug that is excreted unchanged or as metabolites is dependent on pH. When urine pH is uncontrolled, 5-30% of the meperidine dose is excreted as normeperidine and approximately 5% is excreted unchanged. Meperidine and normeperidine are found in acidic urine, while the free and conjugated forms of meperidinic and normperidinic acids are found in alkaline urine.
Half Life: Initial distribution phase (t1/2 α) = 2-11 minutes; terminal elimination phase (t1/2 β) = 3-5 hours. In patients with hepatic dysfunction (e.g. liver cirrhosis or active viral hepatitis) the t1/2 β is prolonged to 7-11 hours.
Affected organisms: Humans and other mammals
Interactions
Food interaction:
Take without regard to meals. Avoid alcohol.
Drug interaction:
RitonavirRitonavir increases the levels of analgesic
TramadolIncreased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.
IsoniazidPossible episodes of hypotension
ChlorpromazineIncreased sedation and hypotension
TrimipramineIncreased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.
show more »

Targets


Enzymes


Carriers